EphA2 as a target for ovarian cancer therapy

Author： Landen Charles N Kinch Michael S Sood Anil K

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.6, 2005-12, pp. : 1179-1187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EphA2 Receptor Tyrosine Kinase as a Promising Target for Cancer Therapeutics

Current Cancer Drug Targets, Vol. 5, Iss. 3, 2005-05 ,pp. : 149-157

Bentham Science Publishers

Access to resources Recommend Favorite

EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors

Current Cancer Drug Targets, Vol. 11, Iss. 9, 2011-11 ,pp. : 1082-1097

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

By Tandon Manish Vemula Sai Vikram Mittal Suresh K

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 31-51

Informa Healthcare

Access to resources Recommend Favorite

The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?

Current Medicinal Chemistry, Vol. 23, Iss. 42, 2016-12 ,pp. : 4718-4734

Bentham Science Publishers

Access to resources Recommend Favorite

Heparanase as a Target in Cancer Therapy

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 286-293

Bentham Science Publishers

Access to resources Recommend Favorite